IMed Group appoints new chief commercial officer
IMed Group has appointed Parminder Kalle as its new Chief Commercial Officer. He brings over 20 years of experience across medical devices, in vitro diagnostics (IVDs), pharma and digital health, combining technical expertise with a proven track record in commercial leadership. In his new role, he will lead IMed Group’s business development and strategic growth